Clinical trials
Not yet recruiting Esophageal Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 13 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hebei Medical University Fourth Hospital | 5 |
| Peking University Cancer Hospital & Institute | 5 |
| Fudan University | 4 |
| Tianjin Medical University Cancer Institute and Hospital | 4 |
| Tang-Du Hospital | 3 |
| The First Affiliated Hospital of Zhengzhou University | 3 |
| Fujian Cancer Hospital | 2 |
| Rui-hua Xu, MD, PhD | 2 |
| Shanghai Chest Hospital | 2 |
| Sichuan University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 60 |
| Esophageal Neoplasms | 8 |
| Recurrence | 2 |
| Anastomotic Leak | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Squamous Cell | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Fistula | 1 |
| Gallbladder Neoplasms | 1 |
Trials
Showing 51 to 60 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.